Market Cap 786.88M
Revenue (ttm) 105.76M
Net Income (ttm) 12.09M
EPS (ttm) N/A
PE Ratio 164.60
Forward PE 63.31
Profit Margin 11.43%
Debt to Equity Ratio 0.00
Volume 43,900
Avg Vol 96,816
Day's Range N/A - N/A
Shares Out 96.31M
Stochastic %K 25%
Beta 1.78
Analysts Sell
Price Target $18.00

Company Profile

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 619 949 3681
Address:
12770 High Bluff Drive, Suite 150, San Diego, United States
Whales22
Whales22 Oct. 23 at 7:01 AM
$TERN $HCTI $GYRE $NBY How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Oct. 15 at 11:18 AM
$GYRE Gyre Therapeutics Has Completed Patient Enrollment In The 52-week Phase 3 Trial In China Of Pirfenidone Capsules, For Pneumoconiosis
0 · Reply
MilsLearning
MilsLearning Oct. 13 at 8:04 AM
$GYRE "L"ets "F" "S"horts 🩳🔥🩳🔥🩳🖕🩳🖕🩳🖕🔜🕖✅ Ever get bullied??? Trading stocks?? Me too!!! Get the bullies out of the schools 🏫 The IPO Foreign Meme movement ***LFS***
0 · Reply
Godwins26
Godwins26 Oct. 10 at 10:10 PM
7th Watchlist for the week 😊 $EPWK $YGMZ $DVLT $GYRE $ORBS
1 · Reply
notreload_ai
notreload_ai Oct. 10 at 1:27 PM
Jefferies began coverage of $GYRE with a Buy rating and a $16 price target. The company is growing in China, aiding its pipeline progress. The lead asset Hydronidone 's Phase 3 study in chronic hepatitis B may lead to a first-in-class launch in China in 2026.
0 · Reply
JarvisFlow
JarvisFlow Oct. 10 at 11:28 AM
Jefferies updates rating for Gyre Therapeutics ( $GYRE ) to Buy, target set at 16.
0 · Reply
JohnnyArtis200
JohnnyArtis200 Sep. 22 at 6:22 AM
$GYRE Marine services cyclicality. Testing support level. Volume decline concerning. Sector headwinds.
0 · Reply
NetworkNewsWire
NetworkNewsWire Sep. 9 at 3:57 PM
BioMedNewsBreaks — $GYRE Advances Toward China Approval and Expands Clinical Pipeline With Hydronidone https://ibn.fm/9wCTA
0 · Reply
Channelchek
Channelchek Sep. 9 at 1:50 PM
Noble Capital Markets Research Report: Gyre Therapeutics, Inc ($GYRE) – Positioned To End YE2025 With Strong Products and Pipeline Development Gyre Has Made Strong YTD Progress. Gyre has made significant progress during the first three quarters of FY2025 that we believe positions the company for a strong year-end. These developments include continued sales growth from two products introduced in 1H25, an application for Hydronidone approval in China, and the start of a Phase 2 clinical trial for Hydronidone in the US. The company also announced the appointment of Dr. Han Ying as the new CEO, a member of the Board of Directors since January 2025. Read more: https://www.channelchek.com/news-channel/gyre-therapeutics-inc-gyre-positioned-to-end-ye2025-with-strong-products-and-pipeline-development
0 · Reply
Arya3t
Arya3t Aug. 31 at 2:57 AM
HuiopkloiuytrewQA $GYRE
0 · Reply
Latest News on GYRE
Whales22
Whales22 Oct. 23 at 7:01 AM
$TERN $HCTI $GYRE $NBY How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Oct. 15 at 11:18 AM
$GYRE Gyre Therapeutics Has Completed Patient Enrollment In The 52-week Phase 3 Trial In China Of Pirfenidone Capsules, For Pneumoconiosis
0 · Reply
MilsLearning
MilsLearning Oct. 13 at 8:04 AM
$GYRE "L"ets "F" "S"horts 🩳🔥🩳🔥🩳🖕🩳🖕🩳🖕🔜🕖✅ Ever get bullied??? Trading stocks?? Me too!!! Get the bullies out of the schools 🏫 The IPO Foreign Meme movement ***LFS***
0 · Reply
Godwins26
Godwins26 Oct. 10 at 10:10 PM
7th Watchlist for the week 😊 $EPWK $YGMZ $DVLT $GYRE $ORBS
1 · Reply
notreload_ai
notreload_ai Oct. 10 at 1:27 PM
Jefferies began coverage of $GYRE with a Buy rating and a $16 price target. The company is growing in China, aiding its pipeline progress. The lead asset Hydronidone 's Phase 3 study in chronic hepatitis B may lead to a first-in-class launch in China in 2026.
0 · Reply
JarvisFlow
JarvisFlow Oct. 10 at 11:28 AM
Jefferies updates rating for Gyre Therapeutics ( $GYRE ) to Buy, target set at 16.
0 · Reply
JohnnyArtis200
JohnnyArtis200 Sep. 22 at 6:22 AM
$GYRE Marine services cyclicality. Testing support level. Volume decline concerning. Sector headwinds.
0 · Reply
NetworkNewsWire
NetworkNewsWire Sep. 9 at 3:57 PM
BioMedNewsBreaks — $GYRE Advances Toward China Approval and Expands Clinical Pipeline With Hydronidone https://ibn.fm/9wCTA
0 · Reply
Channelchek
Channelchek Sep. 9 at 1:50 PM
Noble Capital Markets Research Report: Gyre Therapeutics, Inc ($GYRE) – Positioned To End YE2025 With Strong Products and Pipeline Development Gyre Has Made Strong YTD Progress. Gyre has made significant progress during the first three quarters of FY2025 that we believe positions the company for a strong year-end. These developments include continued sales growth from two products introduced in 1H25, an application for Hydronidone approval in China, and the start of a Phase 2 clinical trial for Hydronidone in the US. The company also announced the appointment of Dr. Han Ying as the new CEO, a member of the Board of Directors since January 2025. Read more: https://www.channelchek.com/news-channel/gyre-therapeutics-inc-gyre-positioned-to-end-ye2025-with-strong-products-and-pipeline-development
0 · Reply
Arya3t
Arya3t Aug. 31 at 2:57 AM
HuiopkloiuytrewQA $GYRE
0 · Reply
MalwareOfMarkets
MalwareOfMarkets Aug. 29 at 4:12 PM
$GYRE god damm waineright buy rating dropping now
0 · Reply
JarvisFlow
JarvisFlow Aug. 26 at 11:30 AM
HC Wainwright & Co. updates rating for Gyre Therapeutics ( $GYRE ) to Buy, target set at 18.
0 · Reply
MalwareOfMarkets
MalwareOfMarkets Aug. 13 at 10:45 PM
$GYRE and 8.27
0 · Reply
MalwareOfMarkets
MalwareOfMarkets Aug. 7 at 3:35 PM
$GYRE now 7.27
0 · Reply
MalwareOfMarkets
MalwareOfMarkets Aug. 1 at 7:45 PM
$GYRE now 666 lucky number?
0 · Reply
Slowhorses
Slowhorses Jul. 23 at 8:59 PM
$ALAR or $GYRE or $ SEMR ??? Any thoughts please which one to go ?
0 · Reply
BrielleX_619
BrielleX_619 Jul. 9 at 1:49 PM
$GYRE ⁨WKSP: U.S. factory ✅ 50%+ prod growth ✅ Doubling margins ✅ Nano-grid + solar Q3 rollout ✅ 1K-truck federal pilot ✅ No China exposure 🔥EYES ON $7+⁩
0 · Reply
Ayed91
Ayed91 Jun. 21 at 1:52 PM
0 · Reply
topstockalerts
topstockalerts Jun. 17 at 1:45 PM
$GYRE not a bad place for a swing idea 💡💡💡
0 · Reply
Razz_FluidX2
Razz_FluidX2 Jun. 17 at 12:42 PM
0 · Reply
CyrusLopez5
CyrusLopez5 Jun. 16 at 7:49 PM
$AMD $BTC.X $XRP.X $GYRE Analyst price target for today🚀 https://lked.in/options-chat-live
0 · Reply